Decosimo

CEO: Optio Labs may pursue 'significant' Series B raise within 12 months

Mar 05, 2015 at 02:25 pm by miltcapps

Updated: OptioLabs announced April 27, 2016 its partnership with Ridge Global. Sept. 30, 2015 the company announced its integration partnership with AMD. It announced further.... Read More

FinTech: New Constructs CEO says accelerator leverage,<br>regulatory initiatives contribute to 'huge tailwind'

Mar 03, 2015 at 03:15 pm by miltcapps

DAVID TRAINER, founder and CEO of investment research analytics player New Constructs LLC, said his emergence from the SixThirty FinTech accelerator in St. Louis coincides wit.... Read More

Ebb & Flow: Former Emdeon SVP relishes growth-oriented CarePayment role

Mar 02, 2015 at 03:15 pm by miltcapps

Updated 7 Dec 2017: Carepayment recruits another $7.5MM SEC filing. 13 March 2017: DFW-area PEs Cedar Springs Capital and Crestline Investors announced that together they acqu.... Read More

Gun.io CEO keeps finger off fund-raising trigger, outlines broad ambitions

Feb 25, 2015 at 03:45 pm by miltcapps

UPDATED 9 Aug 2022 - Nashville-centric CEO Teja Yenamandra, 33, announced completion of a $5.2MM Series A raise that drew investor Tampa-based Ballast Point Ventures. The vint.... Read More

'Proudly capitalist' Jumpstart Foundry unfurls<br>plan for its U.S. and regional ascendancy

Aug 25, 2014 at 10:15 am by miltcapps

ANYONE not familiar with the bluntness and dark humor that sometimes accompany Vic Gatto's impromptu remarks, might have been discomfited when at the end of Jumpstart Foundry'.... Read More

Advisors: LBMC took its time picking pivotal M&A services leader

Aug 25, 2014 at 10:00 am by miltcapps

LATTIMORE BLACK Morgan & Cain, the Brentwood accounting and consulting firm, took at least a year to determine who would be the first fully dedicated transaction-advisory.... Read More

BIONewsTN, Nov. 7, 2011

Nov 07, 2011 at 06:29 am by miltcapps

 Pitt Hyde ► University of Tennessee Research Foundation is host for "Invention to Venture" Friday, Nov. 11, for those interested in entrepreneurship i.... Read More

Commercialization: UTSC's Dale reviews Vaxent's progress on Strep-A vaccine

Nov 06, 2011 at 02:25 pm by miltcapps

Memphis-based Vaxent, the vaccine-development company focused on Group A streptococcus (GAS), is likely to seek a commercialization partner or raise capital by 2014, said co-f.... Read More

Get the Newsletter